skip to the main content area of this page

March 2019 – UNODC: Nine substances and three precursors "scheduled" at the 62nd Session of the Commission on Narcotic Drugs

VIENNA, Austria – March 2019: At its 62nd regular session from 18 to 22 March 2019, the Commission on Narcotic Drugs decided to place nine substances and three precursors under international control. Following recommendations by the WHO, nine substances were added to the relevant schedules of the Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol and the Convention on Psychotropic Substances of 1971. Moreover, following recommendations by the INCB, three precursors, which can be used in the illicit manufacture of amphetamine-type stimulants, were added to Table I of the Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988.

Added to the Single Convention on Narcotic Drugs of 1961, as amended by the 1972 Protocol:

  1. Cyclopropylfentanyl - Schedule I
  2. Methoxyacetylfentanyl - Schedule I
  3. Orthofluorofentanyl (2-Fluorofentanyl) - Schedule I
  4. Parafluorobutyrylfentanyl (4-Fluorobutyrfentanyl) - Schedule I

Added to the Convention on Psychotropic Substances of 1971:

  1. ADB-FUBINACA - Schedule II
  2. FUB‐AMB (MMB‐FUBINACA, AMB‐FUBINACA) - Schedule II
  3. ADB‐CHMINACA  - Schedule II
  4. CUMYL‐4CN-BINACA - Schedule II
  5. N‐Ethylnorpentylone (ephylone) - Schedule II

Added to the Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988:

  1. 3,4-MDP-2P-methylglycidate (PMK glycidate) (all stereoisomers) - Table I 
  2. 3,4-MDP-2P-methylglycidic acid (PMK glycidic acid (all stereoisomers) - Table I 
  3. Alpha-phenylacetoacetamide (APAA) (including its optical isomers) - Table I



For further information please see:

EWA news clip on substances recommended for scheduling by the WHO Expert Committee on Drug Dependence: WHO recommends 9 NPS for scheduling.

For detailed information on the forty-first meeting, substance evaluation and previous committees of the WHO ECDD, please click here.



go back